Case 1 - Relapse following omalizumab discontinuation and response on retreatment.

OriginalsprogEngelsk
TitelCase reports of CSU patients treated with omalizumab.
Publikationsdato2017
Sider38-9
AnsøgerNovartis Pharma AG
StatusUdgivet - 2017

Citationsformater